You fund the trials by being bought out by Gilead or Merck for $150 per share
Sentiment: Strong Buy
Would advise removing your stop gaps as the market may try to manipulate the price to steal shares. have seen it too many times.
I have owned this stock since 2007 at an average buy of $4.61. Any thoughts of what the new study means and any insights to where the other Phase 2 studies are at?